Metrum Research Group is pleased to announce the appointment of Bill Knebel, Pharm.D., Ph.D. as President of the biomedical modeling and simulation services firm.
Tariffville, CT: Over the last twelve years, Metrum has become a global leader in driving data informed decision-making throughout the biomedical research, development, and commercialization process. As the demand for these services and solutions increases, Metrum continues its commitment to delivering superior scientific expertise, the highest quality deliverables, and the growth of the discipline. Appointing Dr. Knebel as president will ensure these priorities are sustained. The skills of the president will be critical in managing operational effectiveness and technical expertise as the organization continues to evolve.
"I am confident that Bill's extensive expertise, leadership skills, and genuine enthusiasm for the work we do, will drive Metrum to continued excellence in execution of our mission", notes Marc Gastonguay, Metrum Research Group co-founder and CEO.
Dr. Knebel joined MetrumRG in 2004 and has been a valued team member over the last 12 years, most recently as Principal Scientist II and Group Leader of the Clinical Pharmacology Modeling and Simulation team. He brings nearly 20 years of experience in applying mathematical modeling and simulation techniques to optimize drug development across academic and industrial settings. Dr. Knebel has taken a leadership role in strengthening Metrum's capabilities and has been a champion of applying high-performance cloud computing environments to facilitate biomedical problem solving.
Metrum Research Group, established in 2004, is a global leader in biomedical modeling and simulation. The group of approximately 25 full time employees has provided strategic decision making for more than 100 companies on over 300 projects.